Table 1 Epidemiological data of the patients (P) and healthy controls (N) recruited in the study.
From: Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF
Patient ID | Age (years) | Sex | HEV IgM | HBsAg | HCV IgG | Bilirubin (mg/dl) | SGOT (IU/ml) | SGPT (IU/ml) |
|---|---|---|---|---|---|---|---|---|
P1 | 58 | Male | + | - | - | 19.1 | 41 | 71 |
P2 | 39 | Male | + | - | - | ND | ND | ND |
P3 | 21 | Male | + | - | - | 2.9 | ND | ND |
P4 | 14 | Male | + | - | - | 9.4 | 620 | 934 |
P5 | 25 | Male | + | - | - | 9.5 | 280 | 476 |
P6 | 24 | Male | + | - | - | 4.6 | 86 | 172 |
P7 | 22 | Male | + | - | - | 9.8 | 106 | 192 |
P8 | 26 | Male | + | - | - | 14 | 386 | 820 |
P9 | 30 | Male | + | - | - | 8 | 292 | 640 |
P10 | 22 | Male | + | - | - | 5.8 | 230 | 510 |
P11 | 30 | Male | + | - | - | 9.6 | 193 | 334 |
P12 | 35 | Male | + | - | - | 4.6 | 116 | 328 |
P13 | 33 | Male | + | - | - | 6.4 | 195 | 393 |
P14 | 24 | Male | + | - | - | 8.5 | 810 | 1040 |
P15 | 39 | Male | + | - | - | 4.1 | 202 | 265 |
P16 | 31 | Male | + | - | - | 9.1 | 356 | 470 |
P17 | 24 | Male | + | - | - | 8.2 | 219 | 348 |
P18 | 36 | Male | + | - | - | 17 | 1453 | 1503 |
P19 | 34 | Male | + | - | - | 20.9 | 1008 | 1170 |
P20 | 29 | Male | + | - | - | 12.8 | 1956 | 2696 |
P21 | 23 | Male | + | - | - | 12.5 | 69 | 176 |
P22 | 35 | Male | + | - | - | 5.2 | 464 | 1476 |
P23 | 40 | Male | + | - | - | 10.4 | 159 | 340 |
P24 | 36 | Male | + | - | - | 6.1 | 2309 | 4266 |
P25 | 51 | Male | + | - | - | 24.3 | 61 | 104 |
N1 | 45 | Male | - | - | - | ND | ND | ND |
N2 | 30 | Male | - | - | - | ND | ND | ND |
N3 | 33 | Male | - | - | - | ND | ND | ND |
N4 | 31 | Male | - | - | - | ND | ND | ND |
N5 | 27 | Male | - | - | - | ND | ND | ND |
N6 | 31 | Male | - | - | - | ND | ND | ND |
N7 | 27 | Male | - | - | - | ND | ND | ND |
N8 | 28 | Male | - | - | - | ND | ND | ND |
N9 | 31 | Male | - | - | - | ND | ND | ND |
N10 | 28 | Male | - | - | - | ND | ND | ND |